The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Calendula cream accelerates wound healing and enhances skin hydration due to its anti-inflammatory antimicrobial and ...

A research team from the Eye & ENT Hospital of Fudan University, China, has developed a novel biocompatible nanoadhesive for ...

Exosomes, naturally occurring extracellular vesicles, have garnered increasing interest in the field of cosmetics and skincare due to their regenerative pr | Drug Discovery And Development ...

Discover the power of hydrogel: researchers at Penn State mimic tissue behaviors using special hydrogels for potential ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

The Australian market has recently seen mixed performance, with the ASX200 closing slightly down by 0.11% at 8,511 points. Despite some sectors facing declines, IT and Staples have shown resilience, ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Keloids are fibrotic scars that extend beyond the boundaries of the original wound, often causing physical disfigurement and emotional distress.

The Zika virus modifies the chemical composition of human skin, making individuals more attractive to mosquitoes. These ...

In an exciting advancement for dermatological science, researchers have uncovered a potential role for vitamin D and the ...